Centrogenic cardiac arrhythmia induced by aconitine: a new "model" for screening of anti-arrhythmic drugs.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000470:Alkaloids; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D001794:Blood Pressure / Q000187:drug effects; D003331:Coronary Vessels; D004195:Disease Models, Animal; D004285:Dogs; D004562:Electrocardiography; D004837:Epinephrine / Q000008:administration & dosage; D005260:Female; D008026:Ligation; D008297:Male; D010672:Phenytoin / Q000494:pharmacology; D011342:Procainamide / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D000470:Alkaloids; D000889:Anti-Arrhythmia Agents; D010672:Phenytoin; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide; D004837:Epinephrine